1,2,3,4,6-Penta-O-pivaloyl-D-mannopyranose - CAS 220017-47-0
Main Product
Product Name:
Catalog Number:
[(2R,3R,4S,5S)-3,4,5,6-tetrakis(2,2-dimethylpropanoyloxy)oxan-2-yl]methyl2,2-dimethylpropanoate; 1,2,3,4,6-Penta-O-pivaloyl-D-mannopyranose; 220017-47-0; SCHEMBL10618469; CTK8B1213; ANW-24664
CAS Number:
Molecular Weight:
Molecular Formula:
Canonical SMILES:
Chemical Structure
CAS 220017-47-0 1,2,3,4,6-Penta-O-pivaloyl-D-mannopyranose

Reference Reading

1.Development assistance for health: past trends, associations, and the future of international financial flows for health.
Dieleman JL1, Schneider MT2, Haakenstad A3, Singh L2, Sadat N2, Birger M2, Reynolds A2, Templin T2, Hamavid H2, Chapin A2, Murray CJ2. Lancet. 2016 Apr 12. pii: S0140-6736(16)30168-4. doi: 10.1016/S0140-6736(16)30168-4. [Epub ahead of print]
BACKGROUND: Disbursements of development assistance for health (DAH) have risen substantially during the past several decades. More recently, the international community's attention has turned to other international challenges, introducing uncertainty about the future of disbursements for DAH.
2.National spending on health by source for 184 countries between 2013 and 2040.
Dieleman JL1, Templin T2, Sadat N2, Reidy P2, Chapin A2, Foreman K2, Haakenstad A3, Evans T4, Murray CJ2, Kurowski C4. Lancet. 2016 Apr 12. pii: S0140-6736(16)30167-2. doi: 10.1016/S0140-6736(16)30167-2. [Epub ahead of print]
BACKGROUND: A general consensus exists that as a country develops economically, health spending per capita rises and the share of that spending that is prepaid through government or private mechanisms also rises. However, the speed and magnitude of these changes vary substantially across countries, even at similar levels of development. In this study, we use past trends and relationships to estimate future health spending, disaggregated by the source of those funds, to identify the financing trajectories that are likely to occur if current policies and trajectories evolve as expected.
3.Prevalence of self-injury performed by adolescents aged 16-19 years.
Pawłowska B1, Potembska E2, Zygo M3, Olajossy M1, Dziurzyńska E4. Psychiatr Pol. 2016;50(1):29-42. doi: 10.12740/PP/36501.
OBJECTIVES: The aim of the study was to assess the prevalence of self-injury among adolescents aged 16-19 years and to indicate demographic variable, selected environmental variables and risky behaviours coexisting with performing self-injuries by the respondents.
4.Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study.
Beesley VL1, Wockner LF2, O'Rourke P2, Janda M3, Goldstein D4,5, Gooden H6, Merrett ND7,8, O'Connell DL9, Rowlands IJ10, Wyld DK11,12, Neale RE2. Support Care Cancer. 2016 Apr 16. [Epub ahead of print]
PURPOSE: This study aims to determine if the supportive care needs of people with pancreatic cancer change over time and identify the factors associated with current and future unmet needs.